DoD Peer Reviewed Cancer, Idea Award
ID: 353914Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353914
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Research Program (PRCRP) Idea Award, aimed at advancing innovative cancer research relevant to military personnel, veterans, and their families. This grant supports high-risk, untested concepts that challenge existing paradigms in cancer research, with a focus on enhancing patient care and treatment options within the Military Health System. With an estimated total program funding of $16 million and the expectation of awarding approximately 20 grants, each project can receive up to $400,000 over a maximum of two years. Interested applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524PRCRPIA_GG.pdf
    The Department of Defense (DOD) is offering the FY24 Peer Reviewed Cancer Research Program (PRCRP) Idea Award, aiming to enhance cancer research relevant to military personnel, veterans, and their families. With an appropriation of $130 million for FY24, this initiative focuses on innovative and untested research concepts with potential high impact. Applications must address congressionally directed topic areas excluding certain cancers and align with defined Military Health Focus Areas to enhance mission readiness. Submissions are due in two phases: a pre-application by June 21, 2024, and a full application by September 26, 2024. The awards will fund specific projects up to $400,000 for a maximum of two years, with expectations for collaborative efforts and innovative approaches that challenge existing methods. The selection process involves a peer review stage followed by a programmatic review for alignment with DOD priorities. The ultimate goal is to decrease the cancer burden on military personnel and improve overall health outcomes. This grant opportunity showcases the DOD’s commitment to addressing unique health challenges faced by service members and their families through targeted research initiatives.
    Similar Opportunities
    DoD Peer Reviewed Cancer, Impact Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Impact Award, aimed at funding high-impact cancer research that benefits Service Members, Veterans, and their families. This grant opportunity seeks to support mature research projects that address critical cancer issues, with a focus on translational or clinical research that demonstrates the potential for significant near-term impact on patient outcomes. With an estimated total program funding of $16 million and the expectation of awarding approximately 10 grants, applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity titled "DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award" for Fiscal Year 2024. This funding initiative aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment and management, particularly for military personnel and their families, addressing specific topic areas related to military health. With an estimated total program funding of $24 million and the expectation of awarding up to five grants, eligible applicants can submit proposals that demonstrate the feasibility and relevance of their clinical trials, with a maximum award amount of $3 million. Interested parties must submit their applications by October 15, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Pancreatic Cancer, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Pancreatic Cancer Research Program (PCARP) Idea Development Award, aimed at supporting innovative research projects that advance the understanding and treatment of pancreatic cancer. This grant opportunity encourages high-risk, high-reward studies that could lead to significant breakthroughs in early detection, supportive care, and the underlying mechanisms of pancreatic cancer, with a total estimated funding of $7.36 million available for approximately eight awards. Eligible applicants include both established and early-career investigators, with a maximum funding limit of $500,000 for single Principal Investigator (PI) applications and $650,000 for partnered applications, emphasizing the importance of collaboration in research efforts. Interested parties should note that the application deadline is October 3, 2024, with a pre-application deadline of June 28, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Rare Cancers, Resource Community Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Rare Cancers Resource and Community Development Award to support research initiatives aimed at improving outcomes for individuals with rare cancers. This grant opportunity seeks to develop clinical or preclinical datasets and research resources that address significant gaps in rare cancer research, emphasizing collaboration among researchers, patients, and clinicians, with a mandatory inclusion of patient advocates in the project planning and implementation phases. With an estimated total funding of $6.4 million available for up to five awards, each project can receive a maximum of $800,000 over a four-year period. Interested applicants must submit a pre-application followed by a full application, with the submission deadline set for September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award (CSCCA) for Fiscal Year 2024. This grant aims to foster transdisciplinary collaborations among scientists, clinicians, and consumer advocates to address urgent issues in cancer research, specifically targeting at least three distinct cancer areas while integrating diverse scientific methodologies. With an estimated total program funding of $32 million and a single award anticipated, applicants must submit a pre-application followed by a full application upon invitation, with the closing date for submissions set for October 15, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Virtual Cancer Center Director Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY24 Peer Reviewed Cancer Virtual Cancer Center Director Award (VCCDA), aimed at enhancing collaborative cancer research relevant to military health. This grant opportunity seeks experienced cancer researchers to lead a virtual cancer center that will support early-career investigators, fostering mentorship and innovative approaches to cancer research through convergent science. With an estimated total program funding of approximately $2.8 million and a budget cap of $1.75 million for individual applications, interested applicants must submit a pre-application by July 24, 2024, and a full application by October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Kidney Cancer, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Kidney Cancer Research Program's Idea Development Award, aimed at advancing innovative and high-impact kidney cancer research. This grant opportunity encourages projects that align with strategic goals such as enhancing understanding of kidney cancer biology, developing novel therapies, and addressing healthcare disparities, with a focus on benefiting active-duty military personnel, veterans, and the general public. The total estimated funding for this program is approximately $18.56 million, with around 13 awards anticipated, and key deadlines include a pre-application due by September 24, 2024, and a full application deadline of October 15, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Breast Cancer, Clinical Research Extension Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Breast Cancer Clinical Research Extension Award, a federal grant aimed at enhancing the impact of breast cancer clinical studies. This grant seeks to extend data collection and analysis from existing clinical trials, focusing on improving patient follow-up and addressing knowledge gaps due to early trial terminations. The program is critical for advancing breast cancer research and ensuring that patient contributions are effectively utilized to save lives. With an estimated total funding of $9.3 million, the award will support one application, with a maximum budget of $5 million for single Principal Investigators or $6 million for those utilizing the Partnering PI option. Interested applicants must submit a pre-application by September 12, 2024, and a full application by September 26, 2024. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.